Your browser is no longer supported. Please, upgrade your browser.
PTE PolarityTE, Inc. daily Stock Chart
PolarityTE, Inc.
Index- P/E- EPS (ttm)-1.69 Insider Own25.20% Shs Outstand38.76M Perf Week-19.53%
Market Cap27.71M Forward P/E- EPS next Y-0.81 Insider Trans-0.93% Shs Float25.34M Perf Month-32.87%
Income-53.90M PEG- EPS next Q-0.19 Inst Own23.30% Short Float9.51% Perf Quarter-47.17%
Sales8.00M P/S3.46 EPS this Y-329.30% Inst Trans-0.19% Short Ratio2.71 Perf Half Y-37.87%
Book/sh0.63 P/B1.07 EPS next Y15.60% ROA-99.60% Target Price- Perf Year-78.42%
Cash/sh0.56 P/C1.19 EPS next 5Y15.00% ROE-160.20% 52W Range0.55 - 4.60 Perf YTD-74.19%
Dividend- P/FCF- EPS past 5Y5.60% ROI-226.70% 52W High-85.76% Beta1.41
Dividend %- Quick Ratio3.10 Sales past 5Y-3.30% Gross Margin59.90% 52W Low18.46% ATR0.11
Employees153 Current Ratio3.20 Sales Q/Q135.70% Oper. Margin- RSI (14)32.05 Volatility15.08% 11.23%
OptionableYes Debt/Eq0.21 EPS Q/Q79.00% Profit Margin- Rel Volume4.56 Prev Close0.67
ShortableYes LT Debt/Eq0.11 Earnings- Payout- Avg Volume889.54K Price0.66
Recom2.40 SMA20-26.53% SMA50-33.74% SMA200-44.17% Volume3,511,104 Change-2.37%
May-01-20Downgrade Oppenheimer Outperform → Perform
Nov-11-19Resumed Cantor Fitzgerald Overweight $50 → $13
Jul-08-19Initiated H.C. Wainwright Buy $8
Mar-21-19Initiated Evercore ISI Outperform $26
Jan-28-19Initiated Northland Capital Outperform $50
Jan-28-19Initiated National Securities Sell $5
Dec-20-18Initiated Piper Jaffray Overweight
Nov-24-20 08:00AM  
Nov-09-20 07:24AM  
Nov-02-20 08:00AM  
Oct-26-20 08:00AM  
Sep-29-20 08:00AM  
Sep-21-20 08:00AM  
Sep-16-20 08:00AM  
Sep-14-20 08:00AM  
Sep-10-20 08:00AM  
Sep-08-20 08:00AM  
Aug-06-20 07:00AM  
Jul-30-20 08:00AM  
Jul-29-20 08:00AM  
Jul-24-20 08:00AM  
Jul-20-20 08:00AM  
Jul-05-20 08:50PM  
Jun-10-20 07:52AM  
Jun-01-20 08:00AM  
May-27-20 11:29AM  
May-11-20 07:00AM  
Apr-30-20 04:15PM  
Apr-21-20 08:00AM  
Apr-17-20 09:01AM  
Apr-13-20 08:00AM  
Apr-08-20 08:00AM  
Apr-06-20 08:00AM  
Apr-01-20 08:00AM  
Mar-15-20 09:26AM  
Mar-12-20 07:00AM  
Mar-05-20 08:00AM  
Mar-03-20 08:00AM  
Feb-18-20 06:38PM  
Feb-12-20 09:24AM  
Feb-11-20 04:01PM  
Dec-19-19 06:29PM  
Dec-18-19 08:00AM  
Dec-12-19 09:11AM  
Dec-10-19 08:00AM  
Dec-06-19 08:00AM  
Dec-05-19 08:00AM  
Nov-28-19 09:42AM  
Nov-27-19 08:00AM  
Nov-19-19 04:55PM  
Nov-12-19 04:05PM  
Nov-07-19 04:01PM  
Oct-24-19 08:00AM  
Oct-14-19 03:36PM  
Oct-06-19 10:00AM  
Oct-03-19 08:00AM  
Sep-26-19 08:00AM  
Sep-23-19 08:00AM  
Sep-18-19 08:00AM  
Sep-16-19 08:00AM  
Sep-09-19 08:00AM  
Sep-04-19 08:00AM  
Aug-28-19 08:00AM  
Aug-20-19 01:43PM  
Aug-16-19 08:00AM  
Aug-08-19 07:00AM  
Jul-25-19 08:00AM  
Jul-24-19 09:35AM  
Jun-29-19 07:17PM  
Jun-19-19 12:30PM  
Jun-12-19 11:49AM  
Jun-10-19 10:09AM  
Jun-08-19 05:38PM  
Jun-03-19 08:00AM  
May-31-19 01:33PM  
May-21-19 08:00AM  
May-20-19 11:26AM  
May-10-19 09:55AM  
May-02-19 09:00AM  
May-01-19 08:00AM  
Apr-24-19 08:00AM  
Apr-10-19 11:00AM  
Apr-09-19 04:01PM  
Apr-02-19 04:34PM  
Apr-01-19 08:00AM  
Mar-29-19 08:00AM  
Mar-27-19 08:00AM  
Mar-21-19 08:00AM  
Mar-19-19 05:00PM  
Mar-18-19 07:56PM  
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lough DenverPrior Director and OfficerNov 01Option Exercise0.0011,11107,181,889Nov 04 04:05 PM
Seaburg David BChief Executive OfficerOct 19Sale1.0231,03231,560919,792Oct 20 04:05 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPOct 19Sale1.039,99910,299587,438Oct 20 04:05 PM
Lough DenverPrior Director and OfficerOct 01Option Exercise0.0011,11107,174,079Oct 05 04:05 PM
Seaburg David BChief Executive OfficerSep 30Sale1.038,5148,795950,824Oct 01 05:29 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPSep 29Sale1.01936945597,437Sep 30 04:05 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPSep 22Sale1.023,5003,570598,373Sep 23 04:05 PM
Seaburg David BChief Executive OfficerSep 02Sale1.135,6006,306959,338Sep 04 04:05 PM
Lough DenverPrior Director and OfficerSep 01Option Exercise0.0011,11107,166,447Sep 03 04:05 PM
Dyer Jeffrey HansenDirectorAug 24Sale1.271,0001,27153,286Aug 25 05:00 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPAug 07Sale1.5311,66717,851601,873Aug 10 04:05 PM
Seaburg David BChief Executive OfficerAug 07Sale1.5316,33424,991964,938Aug 10 04:06 PM
Lough DenverPrior Director and OfficerAug 03Option Exercise0.0011,11107,158,530Aug 05 10:56 AM
Lough DenverPrior Director and OfficerJul 01Option Exercise0.0011,11107,150,671Jul 06 11:11 AM
Seaburg David BChief Executive OfficerJul 01Sale1.288,51410,8811,002,451Jul 02 04:06 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPJun 29Sale1.449361,348622,184Jun 30 04:05 PM
Lough DenverPrior Director and OfficerJun 01Option Exercise0.0011,11207,139,560Jun 03 11:07 AM
Lough DenverPrior Director and OfficerMay 01Option Exercise0.0011,11107,131,786May 05 03:21 PM
Lough DenverPrior Director and OfficerApr 02Option Exercise0.0011,11107,123,878Apr 03 11:45 AM
Mann Paul ElliotChief Financial OfficerMar 31Sale1.0423,15824,084415,953Apr 02 04:30 PM
Seaburg David BChief Executive OfficerMar 31Sale1.0421,28722,138345,965Apr 02 04:30 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPMar 30Sale1.159361,076323,120Mar 31 08:16 PM
Mann Paul ElliotChief Financial OfficerMar 23Sale1.051,2831,347439,111Mar 25 09:05 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPMar 23Sale1.053,5003,675324,056Mar 25 09:03 PM
Lough DenverPrior Director and OfficerMar 03Option Exercise0.0011,11107,116,001Mar 04 07:08 PM
Seaburg David BPresidentMar 03Sale1.345,4507,303367,251Mar 04 04:30 PM
Hague RichardChief Operating OfficerFeb 07Sale3.0212,95039,109321,895Feb 07 09:32 PM
Mann Paul ElliotChief Financial OfficerFeb 07Sale3.0212,83338,756440,393Feb 07 09:30 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPFeb 07Sale3.0411,66735,468327,556Feb 07 09:28 PM
Seaburg David BPresidentFeb 07Sale3.0216,33349,326372,701Feb 07 09:26 PM
Lough DenverPrior Director and OfficerFeb 04Option Exercise0.0011,11107,108,602Feb 05 10:22 AM
Lough DenverPrior Director and OfficerJan 16Option Exercise3.1210,00031,20010,000Jan 21 06:59 PM
Lough DenverPrior Director and OfficerJan 16Sale4.1710,00041,7000Jan 21 06:59 PM
Lough DenverPrior Director and OfficerJan 03Option Exercise0.0011,11107,097,491Jan 06 03:01 PM
Mann Paul ElliotChief Financial OfficerDec 23Sale2.7111,00029,810453,227Dec 23 08:12 PM
Erdtmann Rainer MDirectorDec 16Sale2.4731,84678,66030,000Dec 17 04:30 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.